Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Achiko AG    ACHI   CH0522213468


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Achiko AG Enters into a Convertible Note of Up to CHF $2 Million with Negma Group

11/30/2020 | 08:34am EST

ZURICH, Switzerland, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Achiko AG (SWX:ACHI, ISIN CH0522213468) (“the Company”) has entered into a new subordinated convertible loan transaction of up to CHF $2 million with Negma Group containing a conversion right into registered shares of the Company with a conversion period of 3 years.

The convertible loan transaction will close between January 1 and February 15, 2021 and comes attached with an issuance of 1,500,000 warrants in Negma Group’s favour. Each warrant confers the right to purchase one registered share of the Company, has an exercise period between the 30th and 365th day after the date of issuance of the warrants, and with an exercise price of CHF $0.35 (subject to customary adjustments).

This replaces the existing financing facility with Negma Group and is complementary to the Company’s recent announcements regarding updates to the capital increase of CHF 2.9 million in October and the recent announcement of the convertible note with Yorkville of USD $2.5 million.

“2020 has been critical for us in establishing solid foundations for Teman Sehat and Gumnuts,” said Steven Goh, CEO Achiko AG. “We’re grateful to everyone for their support and the recent transactions establishes the Company for an exciting 2021.”

We create solutions with a great user experience, for the transformation of the healthcare industry.

The development of our patent pending diagnostic testing kit for Covid-19 (Gumnuts) provides an easy and effective way to help people get the information they need. This is complemented by our mobile check-in app (Teman Sehat), enabling users to manage their diagnostic experiences on their own terms, safeguard their privacy, share experiences and find community.

We are headquartered in Zurich, with offices in Hong Kong, Jakarta, Singapore and Seoul. For more information, visit http://www.achiko.com/

Media contacts:

Investor Relations
E: ir@achiko.com

Marcus Balogh
Farner Consulting Ltd.
E: achiko@farner.ch
T: +41 44 266 67 67
Germany and Austria
Axel Mühlhaus / Dr Sönke Knop
edicto GmbH
E: achiko@edicto.de
T: +49 69 90 55 05-51


This communication expressly or implicitly contains certain forward-looking statements concerning Achiko AG and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of Achiko AG to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Achiko AG is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.

Primary Logo

© GlobeNewswire 2020
All news about ACHIKO AG
01/26Achiko's Gumnut COVID-19 Testing Technology Shows High Sensitivity, Specifici..
01/25Achiko Concludes Phase 1 Study of Project Gumnuts for Covid-19 Testing
01/24EQS-ADHOC : Achiko AG: Achiko conclut la phase 1 de l'étude du projet Gumnuts po..
01/24EQS-ADHOC : Achiko AG: Achiko concludes Phase 1 study of Project Gumnuts for Cov..
01/18EQS-ADHOC : Achiko AG invites shareholders to an Extraordinary Shareholders' Mee..
01/12Pitt Street Research Lowers Price Target on Achiko
01/12Achiko Names New President
01/11ACHIKO : Strengthens Leadership Team with New President and New SVP Commercializ..
01/11EQS-ADHOC : Achiko AG: Achiko renforce l'équipe de direction avec nouveau Présid..
01/11ACHIKO AG : Achiko strengthens leadership team with new President and new SVP C..
More news
Financials (USD)
Sales 2020 5,90 M - -
Net income 2020 -5,00 M - -
Net Debt 2020 6,40 M - -
P/E ratio 2020 -8,03x
Yield 2020 -
Capitalization 42,6 M 42,6 M -
EV / Sales 2020 8,31x
EV / Sales 2021 8,08x
Nbr of Employees -
Free-Float -
Duration : Period :
Achiko AG Technical Analysis Chart | ACHI | CH0522213468 | MarketScreener
Technical analysis trends ACHIKO AG
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus SELL
Number of Analysts 1
Average target price 0,03 $
Last Close Price 0,40 $
Spread / Highest target -91,8%
Spread / Average Target -91,8%
Spread / Lowest Target -91,8%
EPS Revisions
Managers and Directors
Steven Goh Chief Executive Officer & Director
Morris S. Berrie President
Yao Bian Wu Chairman
Christopher Young Chief Operating Officer
Sunil Peter Chief Financial Officer